Bart Molemans

Bart Molemans, MD, is an accomplished Executive Medical Director at Amgen, with extensive experience in leading global medical strategies across various therapeutic areas, including Cardiovascular, Metabolic, and Bone. Since joining Amgen in January 2005, Bart has held multiple leadership roles, overseeing teams and fostering collaboration across global and local teams to drive scientific evidence and product strategies. Prior to Amgen, Bart served as Acting Associate Director at Chiron Corporation, focusing on oncology clinical operations in Europe, and as a Medical Adviser at Novo Nordisk Pharmaceuticals, where strategic planning for hormone replacement therapy was a key responsibility. Bart holds a degree from KU Leuven.